Discover 1,567 paid clinical trials in Jersey City, New Jersey. Search by condition or phase to find a research study near you that matches your needs across various therapeutic areas.
Filter
2
Filter results
Results: 1,567
A Study of Elritercept to Treat Anemia in Adults With Very Low, Low, or Intermediate Risk Myelodysplastic Syndromes (MDS)
A Study to Evaluate the Efficacy, Safety, and Pharmacokinetics of Obinutuzumab in Adolescents With Active Class III or IV Lupus Nephritis and the Safety and PK of Obinutuzumab in Pediatric Participants
Location: Hackensack NJ, New Hyde Park NY, Neptune City NJ,
Sponsor: Travere Therapeutics, Inc.
Sex: All
Age: 1 - 17
Code: NCT05003986
Phase2, Recruiting
Interested in new trials?
Get alerts for new trials in your area by subscribing now
XTX301 in Patients With Advanced Solid Tumors
for
Advanced Solid Tumor
Location: Hackensack NJ, New Haven CT, Pittsburgh PA, Canton OH,
Sponsor: Xilio Development, Inc.
Sex: All
Age: 18+
Code: NCT05684965
Phase1, Phase2, Recruiting
A Study to Evaluate Axatilimab and Corticosteroids as Initial Treatment for Chronic Graft-Versus-Host Disease
for
Chronic Graft-versus-host-disease
Location: Hackensack NJ, New Brunswick NJ, Stony Brook NY,
Sponsor: Incyte Corporation
Sex: All
Age: 12+
Code: NCT06585774
Phase3, Recruiting
Comparing the Effectiveness of Matched Related Donor Hematopoietic Stem Cell Transplantation to Disease Modifying Therapy in Pediatric Patients With Sickle Cell Disease
for
Sickle Cell Disease (SCD)
Location: Hackensack NJ, The Bronx NY, Philadelphia PA,
Sponsor: University of Rochester
Sex: All
Age: 3 - 20
Code: NCT06941389
Recruiting
Silmitasertib (CX-4945) in Combination With Chemotherapy for Relapsed Refractory Solid Tumors
VO and Nivolumab vs Physician's Choice in Advanced Melanoma That Progressed on Anti-PD-1 & Anti-CTLA-4 Drugs [IGNYTE-3]
for
Advanced Melanoma
Location: Hackensack NJ, The Bronx NY, Lake Success NY,
Sponsor: Replimune, Inc.
Sex: All
Age: 12+
Code: NCT06264180
Phase3, Recruiting
Utilization of Lung Ultrasound Score in Decision for Minimally Invasive Surfactant Administration
for
Respiratory Distress Syndrome, Newborn,
Location: Hackensack NJ
Sponsor: Hackensack Meridian Health
Sex: All
Age: 0
Code: NCT07442669
Recruiting
Delay AvoIding Primary Evaluation for ThRombectomy of Acute StrokE Patients With Large Vessel OCclusion in the Angiography SuiTe
for
Stroke, Acute
Location: Hackensack NJ, New York NY, Detroit MI, Wyoming MI,
Sponsor: Santiago Ortega Gutierrez
Sex: All
Age: 18+
Code: NCT06825897
Recruiting
Predictive Value of Lung Ultrasound for Respiratory Decompensation in Late Preterm Neonates
for
Pre-Term, Respiratory Distress of Newborn, Premature
Location: Hackensack NJ
Sponsor: Hackensack Meridian Health
Sex: All
Age: 0
Code: NCT07216053
Recruiting
ShortStop-HER2: 12 Months vs. 6 Months of HER2-targeted Medications for People With HER2+ Breast Cancer Who Had a Pathologic Complete Response After Chemotherapy Plus Trastuzumab
for
Anatomic Stage I Breast Cancer AJCC v8,
Location: Hackensack NJ, The Bronx NY, Greenwich CT, Stamford CT,
Sponsor: Alliance for Clinical Trials in Oncology
Sex: All
Age: 18+
Code: NCT06876714
Phase3, Recruiting
Placebo-Controlled Trial of IFx-Hu2.0 Followed By Pembrolizumab In Checkpoint Inhibitor Naïve Participants With Advanced Or Metastatic Merkel Cell Carcinoma
for
Advanced Or Metastatic Merkel Cell Carcinoma
Location: Hackensack NJ, Morristown NJ, Boston MA, Fairfax VA,
Sponsor: TuHURA Biosciences, Inc.
Sex: All
Age: 18+
Code: NCT06947928
Phase2, Phase3, Recruiting
Eflornithine (DFMO) and AMXT 1501 for Neuroblastoma, CNS Tumors, and Sarcomas